Brucella melitensis

Experimental Therapeutics
Poly(d,l-Lactide-Coglycolide) Particles Containing Gentamicin: Pharmacokinetics and Pharmacodynamics in Brucella melitensis- Infected Mice
M. C. Lecaroz, M. J. Blanco-Prieto, M. A. Campanero, H. Salman, C. Gamazo
Mechanisms of Resistance
Functional Characterization of Brucella melitensis NorMI, an Efflux Pump Belonging to the Multidrug and Toxic Compound Extrusion Family
Martine Braibant, Laurence Guilloteau, Michel S. Zygmunt
LETTERS TO THE EDITOR
Comparison of E Test to Microdilution for Determining In Vitro Activities of Antibiotics against Brucella melitensis
D. Gür, S. Kocagöz, M. Akova, S. Un̈al
LETTERS TO THE EDITOR
Increasing Resistance of Brucellae to Co-Trimoxazole
A. Kinsara, A. Al-Mowallad, A. O. Osoba
Susceptibility
In Vitro Activities of Antibiotics Alone and in Combination against Brucella melitensis at Neutral and Acidic pHs
Murat Akova, Deniz Gür, David M. Livermore, Tanil Kocagöz, H. Erdal Akalin
Susceptibility
In Vitro Activities of Six New Fluoroquinolones against Brucella melitensis
Ignacio Trujillano-Martín, Enrique García-Sánchez, Isaías Montes Martínez, María José Fresnadillo, José Elías García-Sánchez, José Ángel García-Rodríguez